Elizabeth Orr - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Elizabeth Orr's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Elizabeth Orr

Elizabeth Orr

Verified

Managing Editor, Policy and Regulatory, Pharma Intelligence

Arlington

Final Covers

gun violence prevention and the role of the media

Doesn’t Cover

gambling,firearms, smoking, vapes, politics

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 1384

  • Medtech Looks For Relief As Trump Hits Pause On Most Tariffs

    By Elizabeth Orr Verified| Citeline Verified Medtech Looks For Relief As Trump Hits Pause On Most TariffsThe medtech industry hopes to use a 90-day pause on tariffs to negotiate a “zero for zero” exemption. However, recent public comments from President Donald Trump suggest the health care sector may still be at risk. (Cagkan Sayin/Shutterstock)

    By Elizabeth Orr Verified · Citeline

    Apr. 09, 2025

  • IMDRF Offers Granular Playbook On ‘Regulatory Reliance’ Program Development And Implementation

    By Elizabeth Orr Verified| Citeline Verified IMDRF Offers Granular Playbook On ‘Regulatory Reliance’ Program Development And ImplementationInternational device regulatory group IMDRF has issued a new playbook on “regulatory reliance,” which allows regulators to make use of assessments performed by trusted regulatory partners. The document is the first to offer a detailed guide on developing and implementing these agreements.

    By Elizabeth Orr Verified · Citeline

    Apr. 08, 2025

  • Medtech Looks For Relief As Trump Hits Pause On Most Tariffs

    By Elizabeth Orr Verified| Citeline Verified Medtech Looks For Relief As Trump Hits Pause On Most TariffsThe medtech industry hopes to use a 90-day pause on tariffs to negotiate a “zero for zero” exemption. However, recent public comments from President Donald Trump suggest the health care sector may still be at risk. (Cagkan Sayin/Shutterstock)

    By Elizabeth Orr Verified · Citeline

    Apr. 09, 2025

As seen in

Company Info

Pharma Intelligence

Arlington, United States